Q2 2024 IP Activity Reveals New Granted Patents in mRNA Delivery and a Newcomer Developing Therapeutic Circular RNA for Pet Vaccination
SOPHIA ANTIPOLIS, France – September 03, 2024 │ The quarterly report for the Q2 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q2 2024 patenting activity maintains steady pace with notable new granted patents in[…]